Macular edema on OCT

Eylea outperforms Avastin for DME in patients with moderate vision loss

A two-year clinical trial that compared three drugs for diabetic macular edema (DME) found that visual improvement was greater for participants receiving the drug Eylea (aflibercept) than for those receiving Avastin (bevacizumab), but only among participants starting treatment with 20/50 or worse vision.  Gains after two years were about the same for Eylea and Lucentis


Surgery in monkey eye

Stem-cell derived retina found to improve vision in monkeys with RP

Researchers at the RIKEN Institute in Japan have succeeded in growing human embryonic stem cell-derived retina (hESC-retina) and transplanting that tissue into the retinas of rhesus monkeys with Retinitis Pigmentosa (RP). Three weeks after the treatment, visual tests on two of the monkeys found their vision had improved. In the study, published in the journal PNAS,


Laser gene delivery system

A gene therapy platform for macular degeneration patients

Physics researchers at The University of Texas at Arlington have developed a new platform that uses ultrafast near-infrared lasers to deliver gene therapy to damaged areas of the retina to enable vision restoration in patients with photo-degenerative diseases such as macular degeneration. Samarenda Mohanty, assistant professor of physics and head of UTA’s Biophysics and Physiology


PRP for diabetic retinopathy

Ranibizumab Found Effective Against Diabetic Retinopathy

In a randomized clinical trial conducted by of more than 300 participants, researchers have found that ranibizumab is an effective alternative to Panretinal photocoagulation (PRP) (laser therapy for treating diabetic retinopathy). Results also show that the drug therapy carries fewer side effects than the currently used laser treatment.

Dr Allen Ho

Less than Half of US Adults Understand Their Risk for Vision Loss from Diabetes

A new survey at the start of Diabetes Awareness Month (by Regeneron Pharmaceuticals Inc.) has found that less than half of recently surveyed U.S. adults with diabetes recognize their risk for vision loss. The survey also found that less than one-fifth (18%) of respondents were familiar with diabetic macular edema (DME). The survey found that nearly one


Patients waiting for an eye exam

Visit to Cochabamba, Bolivia

This visit was supported by a grant from Alcon Foundation. As part of our outreach into South America, we visited Cochabamba in Bolivia the week of Oct 26, 2015. We are collaborating with the Fundación Boliviana de Oftalmología to help develop retinal services in the country. Dr Oscar Cortex and his son, Dr Rodrigo Cortes, manage this